These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1055 related articles for article (PubMed ID: 12496760)

  • 61. DNA methylation of the human oxytocin receptor gene promoter regulates tissue-specific gene suppression.
    Kusui C; Kimura T; Ogita K; Nakamura H; Matsumura Y; Koyama M; Azuma C; Murata Y
    Biochem Biophys Res Commun; 2001 Dec; 289(3):681-6. PubMed ID: 11726201
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia.
    Myöhänen SK; Baylin SB; Herman JG
    Cancer Res; 1998 Feb; 58(4):591-3. PubMed ID: 9485004
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DNA methylation and gene silencing in cancer: which is the guilty party?
    Clark SJ; Melki J
    Oncogene; 2002 Aug; 21(35):5380-7. PubMed ID: 12154400
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Progesterone receptor gene inactivation and CpG island hypermethylation in human leukemia cancer cells.
    Liu ZJ; Zhang XB; Zhang Y; Yang X
    FEBS Lett; 2004 Jun; 567(2-3):327-32. PubMed ID: 15178346
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6.
    Foran E; Garrity-Park MM; Mureau C; Newell J; Smyrk TC; Limburg PJ; Egan LJ
    Mol Cancer Res; 2010 Apr; 8(4):471-81. PubMed ID: 20354000
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.
    Song JZ; Stirzaker C; Harrison J; Melki JR; Clark SJ
    Oncogene; 2002 Feb; 21(7):1048-61. PubMed ID: 11850822
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells.
    Arapshian A; Kuppumbatti YS; Mira-y-Lopez R
    Oncogene; 2000 Aug; 19(35):4066-70. PubMed ID: 10962564
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predicting aberrant CpG island methylation.
    Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12253-8. PubMed ID: 14519846
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
    Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
    Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells.
    Nass SJ; Ferguson AT; El-Ashry D; Nelson WG; Davidson NE
    Oncogene; 1999 Dec; 18(52):7453-61. PubMed ID: 10602504
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aberrant p27Kip1 promoter methylation in malignant melanoma.
    Worm J; Bartkova J; Kirkin AF; Straten P; Zeuthen J; Bartek J; Guldberg P
    Oncogene; 2000 Oct; 19(44):5111-5. PubMed ID: 11042700
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis.
    De Marzo AM; Marchi VL; Yang ES; Veeraswamy R; Lin X; Nelson WG
    Cancer Res; 1999 Aug; 59(16):3855-60. PubMed ID: 10463569
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
    Cheng JC; Auersperg N; Leung PC
    Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpG [correction of non-CpA] sites.
    Gowher H; Jeltsch A
    J Mol Biol; 2001 Jun; 309(5):1201-8. PubMed ID: 11399089
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development.
    Sakashita K; Koike K; Kinoshita T; Shiohara M; Kamijo T; Taniguchi S; Kubota T
    J Clin Invest; 2001 Oct; 108(8):1195-204. PubMed ID: 11602627
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
    Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
    Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation.
    Weisenberger DJ; Velicescu M; Cheng JC; Gonzales FA; Liang G; Jones PA
    Mol Cancer Res; 2004 Jan; 2(1):62-72. PubMed ID: 14757847
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of the human Sd(a) beta-1,4-N-acetylgalactosaminyltransferase II gene is dependent on the promoter methylation status.
    Wang HR; Hsieh CY; Twu YC; Yu LC
    Glycobiology; 2008 Jan; 18(1):104-13. PubMed ID: 17965433
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells.
    Law AY; Lai KP; Ip CK; Wong AS; Wagner GF; Wong CK
    Exp Cell Res; 2008 May; 314(8):1823-30. PubMed ID: 18394600
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms.
    Hopfer O; Komor M; Koehler IS; Freitag C; Schulze M; Hoelzer D; Thiel E; Hofmann WK
    Leuk Res; 2009 Mar; 33(3):434-42. PubMed ID: 18829110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.